The treatment of CLL cells, BMMSCs, or co-cultures of the two with human recombinant IL-17A, induced higher levels of IL-6 mRNA and protein in both CLL cells and BMMSCs. Here, IL17A is linked to B-cell chronic lymphocytic leukemia.